Based on the existing data, we hypothesize that a considerable portion of N-cadherin in glioma cell membranes reported in papers published before the year 2010 is actually proN-cadherin since authors might not have distinguished between proN-cadherin and N-cadherin. The gene discussed is CDH2; the disease is central nervous system cancer.